A combined clinicopathologic and gene expression model (CP-GEP) identifies primary cutaneous melanoma patients who can safely forgo sentinel lymph node biopsy

被引:0
|
作者
Meves, Alexander [1 ]
Arias-Mejias, Suzette [1 ]
Bridges, Alina G. [1 ]
Lehman, Julia S. [2 ]
Pittelkow, Mark R. [2 ]
Cappel, Mark A. [2 ]
Perniciaro, Charles [3 ]
van Vliet, Martin H. [4 ]
Bellomo, Domenico [4 ]
Dwarkasing, Jvalini
Bellomo, Domenico [4 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Gulf Coast Dermatopathol Lab, Tampa, FL USA
[3] Univ Florida, Coll Med, Gainesville, FL 32611 USA
[4] SkylineDx BV, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
18408
引用
收藏
页码:AB99 / AB99
页数:1
相关论文
共 50 条
  • [41] Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now
    Medalie, N
    Ackerman, AB
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (02) : 298 - 307
  • [42] Patterns of first recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy
    Dalal, KM
    Panageas, KS
    Patel, A
    Brady, MS
    Jaques, DP
    Coit, DG
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 74 - 75
  • [43] Methods of Detection of First Recurrence in Patients with Stage I/II Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy
    Kimberly Moore Dalal
    Qin Zhou
    Katherine S. Panageas
    Mary S. Brady
    David P. Jaques
    Daniel G. Coit
    Annals of Surgical Oncology, 2008, 15
  • [44] The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study
    Yamamoto, Maki
    Sickle-Santanello, Brenda
    Beard, Timothy
    Essner, Richard
    Martin, Brian
    Bailey, Christine N. N.
    Guenther, J. Michael
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (03) : 417 - 423
  • [45] Prognostic Usefulness of Sentinel Lymph Node Biopsy for Patients Who Have Clinically Node Negative, Localized, Primary Invasive Cutaneous Melanoma A Bayesian Analysis Using Informative Published Reports
    Rhodes, Arthur R.
    ARCHIVES OF DERMATOLOGY, 2011, 147 (04) : 408 - 415
  • [46] Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence
    Clary, BM
    Brady, MS
    Lewis, JJ
    Coit, DG
    ANNALS OF SURGERY, 2001, 233 (02) : 250 - 258
  • [47] Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy
    Dalal, Kimberly M.
    Patel, Ami
    Brady, Mary S.
    Jaques, David P.
    Coit, Daniel G.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) : 1934 - 1942
  • [48] Patterns of First-Recurrence and Post-recurrence Survival in Patients with Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy
    Kimberly M. Dalal
    Ami Patel
    Mary S. Brady
    David P. Jaques
    Daniel G. Coit
    Annals of Surgical Oncology, 2007, 14 : 1934 - 1942
  • [49] Use of Merlin Assay to identify patients with a low-risk for SN metastasis in a prospective multicenter Dutch study of a primary melanoma gene-signature (CP-GEP model) to predict sentinel node status during COVID-19.
    Stassen, Robert
    Mulder, Evalyn
    Veringa, Antoine
    Mooyaart, Antien
    Dwarkasing, Jvalini
    Tempel, Dennie
    Van der Hage, Jos A.
    Lendfers, Sandra
    Aarts, Maureen J. B.
    Verhoef, Cornelis
    Francken, Anne Brecht
    Grunhagen, Dirk J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma
    Guenther, J. Michael
    Ward, Andrew
    Martin, Brian J.
    Cripe, Mark
    Sharma, Rohit
    Leong, Stanley P.
    Clark, Joseph I.
    Hamner, John
    Beard, Timothy
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)